The Urbanek TMJ Device and Protocol launched operations in North America, offering a solution for treating TMJ/TMD sufferers.
The Urbanek TMJ Device and Protocol announced today the official launch of its commercial operations in North America, offering dental professionals a new way to treat the over 10 million TMD/TMJ sufferers in the United States.
“After more than 4,000 cases treated with a 95% success rate, we’re excited to finally offer this solution nationwide to treat the growing epidemic of TMD,” said Anthony Urbanek, DDS, Urbanek chief executive officer and founder. “With this FDA-cleared medical device and our comprehensive training and support, dental care providers can now offer their patients an easy and affordable solution.”
Developed by an oral maxillofacial surgeon with over 40 years of experience, the Urbanek Device and Protocol is a non-surgical, custom CAD-CAM, 3D-printed resin device that alleviates the inflammation of the TMD joint.
Unlike a nightguard, this FDA-cleared medical device was specifically designed to treat the root cause of TMD.
“It’s our mission to provide dental care professionals with a system to safely eliminate TMJ/TMD for their patients without surgery or medications,” said Urbanek.
Photo courtesy of Urbanek TMJ Device and Protocol
